Building on strategic co-incubation partnership, HKSTP and Boehringer Ingelheim Venture Fund Limited (BIVF) will be hosting Boehringer Ingelheim x Incu-Bio Open Day on November 29th, 2024, in Hong Kong Science Park.
At this event, BIVF will be showcasing their various business units and functions such as venture fund, external innovation, business development and licensing, and CDMO services, with the purpose of exploring collaborations with the Hong Kong biomedical technology ecosystem. Biomedical companies residing at Hong Kong Science Park and incubatees of Incu-Bio will be pitching and showcasing their innovative technologies.